The PP2A is implicated in human cell transformation and in cell cycle progression and its inhibition eradicated the cancer subpopulation of leukemic stem cells responsible for TKI resistance and minimal residual disease (Lai et al., 2018). The gene discussed is PTPA; the disease is cancer.